Expression of Concern: MAML1 Acts Cooperatively with EGR1 to Activate EGR1-Regulated Promoters: Implications for Nephrogenesis and the Development of Renal Cancer

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPI3K/AKT/mTOR signaling in cancer · Wnt/β-catenin signaling in development and cancer · Renal cell carcinoma treatment
After publication of this article [1], concerns were raised about Figs 1- 4. Specifically, when color levels are adjusted, there appear to be vertical discontinuities between the following lanes:
Additionally, in Fig 4C, the disclosed splice line between MAML1 (75–1016) and MAML1 (1–625) of the WB: MAML1 panel is not present in the corresponding WB: GAPDH panel.
The first author agreed with the concerns noted in Fig 4C, but not the concerns noted in the other figures. Authors MLH and BF further stated that the concerns outlined above have no impact on the scientific conclusions of the study.
Authors MLH and BF stated that the original images underlying the figures presented in [1] are no longer available as the institutional data retention period has elapsed. In the absence of the underlying image data, the above concerns cannot be fully resolved.
The PLOS One Editors issue this Expression of Concern to notify readers of the above concerns.
The corresponding author of [1] is deceased. Henceforth, correspondence may be sent to the first author, MLH ([email protected]).
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Hansson ML, Behmer S, Ceder R, Mohammadi S, Preta G, Grafström RC, et al. MAML 1 acts cooperatively with EGR 1 to activate EGR 1-regulated promoters: implications for nephrogenesis and the development of renal cancer. P Lo S One. 2012;7(9):e 46001. doi: 10.1371/journal.pone.0046001 23029358 PMC 3459946 · doi ↗ · pubmed ↗
